Ampio Pharmaceuticals, Inc. (NYSE:AMPE) has a beta value of 1.85 and has seen 3,997,643 shares traded in the recent trading session. The company, currently valued at $109.63 Million, closed the recent trade at $0.665 per share which meant it lost $0 on the day or 6.4% during that session. The AMPE stock price is -36.84% off its 52-week high price of $0.91 and 60.9% above the 52-week low of $0.26. If we look at the company’s 10-day average daily trading volume, we find that it stood at 8.74 Million shares traded. The 3-month trading volume is 2.57 Million shares.

The consensus among analysts is that Ampio Pharmaceuticals, Inc. (AMPE) is a Buy stock at the moment, with a recommendation rating of 2. None of the analysts rate the stock as a Sell, while none rate it as Overweight. None out of 1 have rated it as a Hold, with 1 advising it as a Buy. None have rated the stock as Underweight. The expected earnings per share for the stock is -$0.04.

Ampio Pharmaceuticals, Inc. (NYSE:AMPE) trade information

Sporting 6.93% in the green today, the stock has traded in the green over the last five days, with the highest price hit on Monday, Jun 29 when the AMPE stock price touched $0.6999 or saw a rise of 5%. Year-to-date, Ampio Pharmaceuticals, Inc. shares have moved 14.05%, while the 5-day performance has seen it change 10.91%. Over the past 30 days, the shares of Ampio Pharmaceuticals, Inc. (NYSE:AMPE) have changed 23.93%. Short interest in the company has seen 12.19 Million shares shorted with days to cover at 4.74.

Wall Street analysts have a consensus price target for the stock at $4, which means that the shares’ value could jump 501.5% from current levels. The projected low price target is $4 while the price target rests at a high of $4. In that case, then, we find that the current price level is +501.5% off the targeted high while a plunge would see the stock lose 501.5% from current levels.

Ampio Pharmaceuticals, Inc. (AMPE) estimates and forecasts

If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was +29.6% over the past 5 years. Earnings growth for 2020 is a modest -122.5% while over the next 5 years, the company’s earnings are expected to increase by 0%.

Ampio Pharmaceuticals, Inc. (NYSE:AMPE)’s Major holders

Insiders own 8.65% of the company shares, while shares held by institutions stand at 12.07% with a share float percentage of 13.21%. Investors are also buoyed by the number of investors in a company, with Ampio Pharmaceuticals, Inc. having a total of 80 institutions that hold shares in the company. The top two institutional holders are Vanguard Group, Inc. (The) with over 5.35 Million shares worth more than $2.22 Million. As of March 30, 2020, Vanguard Group, Inc. (The) held 3.25% of shares outstanding.

The other major institutional holder is SRS Capital Advisors, Inc., with the holding of over 1.77 Million shares as of March 30, 2020. The firm’s total holdings are worth over $733.79 Thousand and represent 1.07% of shares outstanding.

Also the top two Mutual Funds that are holding company’s shares are Vanguard Total Stock Market Index Fund and Vanguard Extended Market Index Fund. As of March 30, 2020, the former fund manager holds about 2.1% shares in the company for having 3462732 shares of worth $1.44 Million while later fund manager owns 1.73 Million shares of worth $717.02 Thousand as of March 30, 2020, which makes it owner of about 1.05% of company’s outstanding stock.